Literature DB >> 9309680

Identification of mitochondrial deficiency using principal component analysis.

G Durrieu1, T Letellier, J Antoch, J M Deshouillers, M Malgat, J P Mazat.   

Abstract

The mitochondrial pathologies are a heterogeneous group of metabolic disorders that are characterized by anomalies of oxidative phosphorylation, especially in the respiratory chain. The diagnosis of these pathologies involves many investigations among which biochemical study is at present the main tool. However, the analysis of the results obtained during such study remains complex and often does not make it possible to conclude clearly if a patient is affected or not by a biochemical and/or bioenergetic deficiency. This arises from two main problems: 1. The determination of control values from the whole set of variable values (affected and unaffected people). 2. The small size of the population studied and the large number of variables collected which present a rather large variability. To cope with these problems, the principal component analysis method is applied to the results obtained during our biochemical studies. This analysis makes it possible for each respiratory chain complex, to distinguish clearly two subsets of the whole population (affected and unaffected people) as well as to detect the variables which are the most discriminative.

Entities:  

Mesh:

Year:  1997        PMID: 9309680

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  23 in total

Review 1.  Principal component analysis and exploratory factor analysis.

Authors:  I T Joliffe; B J Morgan
Journal:  Stat Methods Med Res       Date:  1992       Impact factor: 3.021

2.  Rapid detection of the A----G(8344) mutation of mtDNA in Italian families with myoclonus epilepsy and ragged-red fibers (MERRF).

Authors:  M Zeviani; P Amati; N Bresolin; C Antozzi; G Piccolo; A Toscano; S DiDonato
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

3.  A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study.

Authors:  R LUFT; D IKKOS; G PALMIERI; L ERNSTER; B AFZELIUS
Journal:  J Clin Invest       Date:  1962-09       Impact factor: 14.808

4.  Mitochondrial DNA deletion in Pearson's marrow/pancreas syndrome.

Authors:  A Rotig; M Colonna; J P Bonnefont; S Blanche; A Fischer; J M Saudubray; A Munnich
Journal:  Lancet       Date:  1989-04-22       Impact factor: 79.321

5.  Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy.

Authors:  D C Wallace; G Singh; M T Lott; J A Hodge; T G Schurr; A M Lezza; L J Elsas; E K Nikoskelainen
Journal:  Science       Date:  1988-12-09       Impact factor: 47.728

Review 6.  Mitochondrial diseases: genotype versus phenotype.

Authors:  D C Wallace
Journal:  Trends Genet       Date:  1993-04       Impact factor: 11.639

7.  Differential investigation of the capacity of succinate oxidation in human skeletal muscle.

Authors:  J C Fischer; W Ruitenbeek; J A Berden; J M Trijbels; J H Veerkamp; A M Stadhouders; R C Sengers; A J Janssen
Journal:  Clin Chim Acta       Date:  1985-11-29       Impact factor: 3.786

8.  Respiration-deficient cells are caused by a single point mutation in the mitochondrial tRNA-Leu (UUR) gene in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS).

Authors:  Y Kobayashi; M Y Momoi; K Tominaga; H Shimoizumi; K Nihei; M Yanagisawa; Y Kagawa; S Ohta
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

9.  The control of mitochondrial oxidations by complex III in rat muscle and liver mitochondria. Implications for our understanding of mitochondrial cytopathies in man.

Authors:  R W Taylor; M A Birch-Machin; K Bartlett; S A Lowerson; D M Turnbull
Journal:  J Biol Chem       Date:  1994-02-04       Impact factor: 5.157

10.  A tRNA(Lys) mutation in the mtDNA is the causal genetic lesion underlying myoclonic epilepsy and ragged-red fiber (MERRF) syndrome.

Authors:  A S Noer; H Sudoyo; P Lertrit; D Thyagarajan; P Utthanaphol; R Kapsa; E Byrne; S Marzuki
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.